z-logo
open-access-imgOpen Access
A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation
Author(s) -
Charity Duran,
Allison J. Burbank,
Kingston H. G. Mills,
Heather Duckworth,
Maria M. Aleman,
Matthew J. Kesic,
David B. Peden,
Yinghao Pan,
Haibo Zhou,
Michelle L. Hernandez
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/11jf-dt18
Subject(s) - sulforaphane , inflammation , proof of concept , activator (genetics) , immunology , chemistry , medicine , biochemistry , computer science , operating system , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom